Overall Earnings Trend and Market Cap Analysis

The latest quarter saw a clear upward trajectory in the proportion of companies reporting positive earnings, rising to 56.0% from 46.0% in December 2025, 44.0% in September 2025, and 41.0% in June 2025. This steady improvement over four consecutive quarters signals a robust recovery phase for Indian corporates after a period of subdued performance.

Breaking down by market capitalisation, mid cap companies led the charge with 66.0% delivering positive results, outperforming both small caps at 55.0% and large caps at 50.0%. This suggests that mid-sized firms are currently benefiting from favourable market conditions and operational leverage, while large caps are showing signs of stabilisation after a challenging period.

Sectoral Standouts and Top Performers

Among large caps, Muthoot Finance emerged as a top performer within the Non-Banking Financial Company (NBFC) sector, demonstrating resilience amid tightening credit conditions. Its ability to sustain profitability highlights the sector’s gradual recovery and improved asset quality.

In the mid cap space, Multi Commodity Exchange (Multi Comm. Exc.) stood out in the Capital Markets sector, benefiting from increased trading volumes and heightened investor participation. This reflects a broader trend of renewed market activity and investor confidence.

Small caps showcased remarkable performances, with Puravankara in Realty, Navin Fluorine International in Specialty Chemicals, and Thangamayil Jewellery in Gems, Jewellery and Watches leading the pack. These companies reported strong earnings growth, driven by sector-specific tailwinds such as real estate demand revival, specialty chemical exports, and festive season jewellery sales.

In-Depth Look: Viyash Scientific Ltd’s Exceptional Quarter

Among the recent declarations, Viyash Scientific Ltd, a Pharmaceuticals & Biotechnology company, reported an outstanding quarter ending March 2026. The company’s net sales surged by 129.02% to ₹919.96 crores, marking its highest quarterly sales to date. Operating profit to interest ratio reached an impressive 12.69 times, underscoring strong operational efficiency and debt servicing capability.

Profit before tax (excluding other income) soared by 629.29% to ₹109.32 crores, while net profit after tax grew by 446.4% to ₹52.11 crores. The company also posted its highest PBDIT of ₹184.25 crores this quarter. Despite a slight dip in its mojo score from 35 to 33 over the past three months, Viyash Scientific’s financial performance remains robust, reflecting strong demand and effective cost management.

Sectoral Patterns and Earnings Quality

The earnings season reveals a mixed but generally positive sectoral landscape. Financial services, particularly NBFCs and capital markets, are showing signs of recovery with improved asset quality and trading activity. Realty and specialty chemicals sectors are benefiting from cyclical upturns and export demand respectively, while consumer discretionary segments like jewellery are capitalising on seasonal demand.

However, the large cap segment’s 50.0% positive result ratio indicates ongoing challenges for some heavyweight companies, possibly due to global macroeconomic uncertainties and inflationary pressures. Mid and small caps appear more nimble, leveraging growth opportunities in niche sectors and domestic demand revival.

Upcoming Earnings to Watch

Investors should keep an eye on the upcoming results of marquee companies such as Max Healthcare Institute Ltd, GAIL (India) Ltd, and ITC Ltd, all scheduled to report on 21 May 2026. These companies operate in healthcare, energy, and FMCG sectors respectively, and their performance will provide further clarity on sectoral momentum and broader market sentiment heading into the next quarter.

Implications for Investors

The improving trend in quarterly earnings, especially the strong showing by mid and small caps, suggests a favourable environment for selective stock picking. Investors may consider focusing on companies demonstrating sustainable profit growth, operational efficiency, and sectoral tailwinds. The recovery in NBFCs and capital markets also points to opportunities in financial services, while cyclical sectors like realty and specialty chemicals merit attention for their growth potential.

Nonetheless, caution is warranted for large caps facing margin pressures and global headwinds. A balanced portfolio approach, combining stable large caps with high-growth mid and small caps, could be prudent in navigating the evolving market landscape.

Summary

The March 2026 quarter earnings season marks a significant improvement in corporate profitability across market capitalisations and sectors. With 56.0% of companies reporting positive results, up from 41.0% just a year ago, the data reflects a broad-based recovery. Mid caps lead with a 66.0% positivity rate, while large caps show signs of stabilisation. Standout performers such as Muthoot Finance, Multi Commodity Exchange, and Puravankara highlight sector-specific strengths. Exceptional results from companies like Viyash Scientific Ltd further underscore the earnings momentum. Upcoming results from key players will be critical in shaping market outlook for the remainder of 2026.